The Daily Debate
CAR-T Cell Therapy: New Hope for Patients?
For our first day’s debate, we focus CAR-T cell therapy, newly approved in the USA and Europe, but how difficult is it to implement, and which patients will it ultimately help. Prof. Christian Chabannon (Chair, EBMT Cell Therapy & Immunobiology Working Party), Prof. Alvaro Urbano-Ispizua and Dr Silvia Montoto tell us more.
Social Media Lab at the APHA 2014 Meeting
APHA 2014